Rho, a full-service CRO, will highlight its expertise in CNS research at the World CNS Summit, taking place February 20-22 in Boston.
WHAT: Rho, a full-service contract research organization (CRO), will highlight its expertise in CNS research at the World CNS Summit, taking place February 20-22 in Boston.
Bringing together more than 100 scientists and executives from biopharma and academia, the World CNS Summit exclusively focuses on empowering translational neurodegenerative research. As a sponsor of and exhibitor at the summit, Rho will emphasize its focus on their extensive experience conducting CNS clinical studies.
Rho focuses on helping pharmaceutical and biotechnology companies bring their products to market through high-quality clinical research services, including clinical operations, project management, data management, data standards, and biostatistics, with extensive experience in many therapeutic areas.
WHO: Rho experts at the World CNS Summit:
- David Cass, senior director, business development
- Alexander Padgett, development associate
- Sheila Bello-Irizarry, research scientist
WHEN: February 20-22, 2018
WHERE: The Westin Copley Place
10 Huntington Ave
Boston, MA 02116
DETAILS: For media inquiries, please contact Kelly Maicon at Largemouth Communications, 919.741.9784, kmaicon@largemouthpr.com.
ABOUT: Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For 34 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. For more information, please visit www.rhoworld.com and follow us on Twitter.
